SE447995B - Mellanprodukt for framstellning av pencillansyra-1,1-dioxider - Google Patents

Mellanprodukt for framstellning av pencillansyra-1,1-dioxider

Info

Publication number
SE447995B
SE447995B SE8305916A SE8305916A SE447995B SE 447995 B SE447995 B SE 447995B SE 8305916 A SE8305916 A SE 8305916A SE 8305916 A SE8305916 A SE 8305916A SE 447995 B SE447995 B SE 447995B
Authority
SE
Sweden
Prior art keywords
dioxides
preparation
pencillanic acid
pencillanic
acid
Prior art date
Application number
SE8305916A
Other languages
English (en)
Swedish (sv)
Other versions
SE8305916L (sv
SE8305916D0 (sv
Inventor
W E Barth
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27122691&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE447995(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of SE8305916L publication Critical patent/SE8305916L/xx
Publication of SE8305916D0 publication Critical patent/SE8305916D0/xx
Publication of SE447995B publication Critical patent/SE447995B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE8305916A 1977-06-07 1983-10-27 Mellanprodukt for framstellning av pencillansyra-1,1-dioxider SE447995B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80432077A 1977-06-07 1977-06-07
US87938178A 1978-02-21 1978-02-21

Publications (3)

Publication Number Publication Date
SE8305916L SE8305916L (sv) 1983-10-27
SE8305916D0 SE8305916D0 (sv) 1983-10-27
SE447995B true SE447995B (sv) 1987-01-12

Family

ID=27122691

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7806628A SE436206B (sv) 1977-06-07 1978-06-06 Penicillansyra-1,1-dioxider med antibakteriell verkan
SE8305916A SE447995B (sv) 1977-06-07 1983-10-27 Mellanprodukt for framstellning av pencillansyra-1,1-dioxider

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7806628A SE436206B (sv) 1977-06-07 1978-06-06 Penicillansyra-1,1-dioxider med antibakteriell verkan

Country Status (35)

Country Link
AR (1) AR224111A1 (xx)
AT (2) AT360649B (xx)
AU (1) AU513636B2 (xx)
BE (1) BE867859A (xx)
BG (2) BG34614A3 (xx)
CH (1) CH634073A5 (xx)
CS (1) CS208472B2 (xx)
DD (2) DD140888A5 (xx)
DE (2) DE2824535C3 (xx)
DK (1) DK155740C (xx)
EG (1) EG13869A (xx)
FI (1) FI66003C (xx)
FR (2) FR2393804A1 (xx)
GB (1) GB2000138B (xx)
GR (1) GR72255B (xx)
HK (1) HK13184A (xx)
HU (1) HU180042B (xx)
IE (1) IE47079B1 (xx)
IL (2) IL54867A (xx)
IN (1) IN149747B (xx)
IT (1) IT1096381B (xx)
KE (1) KE3355A (xx)
LU (1) LU79774A1 (xx)
MY (1) MY8500092A (xx)
NL (2) NL180009C (xx)
NO (2) NO151746C (xx)
NZ (1) NZ187476A (xx)
OA (1) OA05964A (xx)
PH (3) PH26810A (xx)
PL (1) PL114501B1 (xx)
PT (1) PT68146A (xx)
SE (2) SE436206B (xx)
SG (1) SG65383G (xx)
SU (1) SU860706A1 (xx)
YU (1) YU41829B (xx)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU77306A1 (xx) * 1977-05-09 1979-01-18
DE2912511C2 (de) * 1977-06-07 1982-06-24 Pfizer Inc., 10017 New York, N.Y. Pharmazeutische Zusammensetzung, enthaltend Penicillansäure
DK155942C (da) * 1977-12-23 1989-10-23 Pfizer Analogifremgangsmaade til fremstilling af 6-aminopenicillansyre-1,1-dioxid og fysiologisk acceptable syreadditions- og basesalte deraf.
JPS54126735A (en) * 1978-03-24 1979-10-02 Toyama Chem Co Ltd Bactericidal composition for medical use
US4241050A (en) * 1978-09-01 1980-12-23 Pfizer Inc. Penam 1,1-dioxides as beta-lactamase inhibitors
CA1158639A (en) * 1978-12-11 1983-12-13 Eric M. Gordon 6-bromopenicillanic acid sulfone
IE49880B1 (en) * 1979-02-13 1986-01-08 Leo Pharm Prod Ltd Penicillin derivatives
US4420426A (en) 1979-03-05 1983-12-13 Pfizer Inc. 6-Alpha-halopenicillanic acid 1,1-dioxides
SE449103B (sv) * 1979-03-05 1987-04-06 Pfizer Sett att framstella penicillansyra-1,1-dioxid samt estrar derav
US4714761A (en) * 1979-03-05 1987-12-22 Pfizer Inc. 6,6-dihalopenicillanic acid 1,1-dioxides and process
GB2045236A (en) * 1979-03-26 1980-10-29 Hoechst Uk Ltd Oxapenem derivatives
US4309347A (en) * 1979-05-16 1982-01-05 Pfizer Inc. Penicillanoyloxymethyl penicillanate 1,1,1',1'-tetraoxide
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
IE49768B1 (en) * 1979-05-21 1985-12-11 Leo Pharm Prod Ltd 6beta-halopenicillanic acid derivatives
DE3051044C2 (xx) * 1979-06-19 1989-03-30 Leo Pharmaceutical Products Ltd. A/S (Loevens Kemiske Fabrik Produktionsaktieselskab), Ballerup, Dk
US4256733A (en) * 1979-09-26 1981-03-17 Pfizer Inc. Acetoxymethyl penam compounds as β-lactamase inhibitors
US4432970A (en) * 1979-11-23 1984-02-21 Pfizer Inc. 6-beta-Halopenicillanic acid 1,1-dioxides as beta-lactamase inhibitors
IL61880A (en) * 1980-01-21 1984-11-30 Bristol Myers Co 2beta-chloromethyl-2alpha-methylpenam-3alpha-carboxylic acid sulfone derivatives,their preparation and pharmaceutical compositions containing them
US4488994A (en) * 1980-09-08 1984-12-18 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4432903A (en) * 1980-09-08 1984-02-21 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4474698A (en) * 1980-12-11 1984-10-02 Pfizer Inc. Process for preparing esters of penicillanic acid sulfone
US4419284A (en) * 1981-03-23 1983-12-06 Pfizer Inc. Preparation of halomethyl esters (and related esters) of penicillanic acid 1,1-dioxide
EP0069962B1 (en) * 1981-07-15 1985-01-02 Kanebo, Ltd. Novel ester of 1,1-dioxopenicillanic acid, process for production thereof, and use thereof as beta-lactamase inhibitor
PT76527B (en) * 1982-04-19 1985-12-09 Gist Brocades Nv A process for the preparation of penicillanic acid 1,1-dioxide and derivatives thereof
US4502988A (en) * 1983-08-08 1985-03-05 Eli Lilly And Company Oxidation process
EP0139047A1 (en) * 1983-10-18 1985-05-02 Gist-Brocades N.V. Process for the preparation of 6,6-dibromopenicillanic acid 1,1-dioxide
US4647457A (en) * 1983-12-16 1987-03-03 Hoffmann-La Roche Inc. Penicillanic acid derivatives
WO1987006230A1 (en) * 1986-04-10 1987-10-22 Leo Pharmaceutical Products Ltd. A/S Method for preparing penicillanic acid derivatives
GB8808701D0 (en) * 1988-04-13 1988-05-18 Erba Carlo Spa Beta-lactam derivatives
CN102977120B (zh) * 2012-12-14 2015-05-27 江西富祥药业股份有限公司 一种舒巴坦匹酯制备及结晶方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3197466A (en) * 1961-10-30 1965-07-27 Smith Kline French Lab Penicillin sulfoxides and process
LU77306A1 (xx) * 1977-05-09 1979-01-18
EP0000636A1 (en) * 1977-07-13 1979-02-07 Glaxo Group Limited Penem compounds, processes for their preparation, their use in pharmaceutical compositions and azetidinones used in their preparation

Also Published As

Publication number Publication date
DD140888A5 (de) 1980-04-02
IL54867A (en) 1981-11-30
IL54867A0 (en) 1978-08-31
GB2000138B (en) 1982-03-03
AT360649B (de) 1981-01-26
SE7806628L (sv) 1978-12-08
LU79774A1 (fr) 1980-01-22
PH26810A (en) 1992-11-05
NL930064I1 (nl) 1993-09-01
GB2000138A (en) 1979-01-04
PL207396A1 (pl) 1979-06-04
DK155740C (da) 1989-10-23
SU860706A1 (ru) 1981-08-30
NO823126L (no) 1978-12-08
IL62168A0 (en) 1981-03-31
IT1096381B (it) 1985-08-26
SE8305916L (sv) 1983-10-27
PT68146A (en) 1978-07-01
BE867859A (fr) 1978-12-06
PH21116A (en) 1987-07-16
ATA411278A (de) 1980-06-15
FI781800A (fi) 1978-12-08
NO151746C (no) 1985-06-05
SG65383G (en) 1985-03-29
DE2824535A1 (de) 1978-12-14
IN149747B (xx) 1982-04-03
CS208472B2 (en) 1981-09-15
ATA128580A (de) 1981-02-15
NL180009C (nl) 1986-12-16
NO151746B (no) 1985-02-18
DE2824535C3 (de) 1981-01-22
PL114501B1 (en) 1981-02-28
YU41829B (en) 1988-02-29
DE2857263B2 (de) 1981-04-23
DK251478A (da) 1978-12-08
FR2393805A1 (fr) 1979-01-05
FR2393804A1 (fr) 1979-01-05
BG34614A3 (en) 1983-10-15
NL930064I2 (nl) 1994-04-18
DE2857263C3 (de) 1981-12-17
AU513636B2 (en) 1980-12-11
BG34615A3 (en) 1983-10-15
DK155740B (da) 1989-05-08
CH634073A5 (en) 1983-01-14
NZ187476A (en) 1982-08-17
PH16465A (en) 1983-10-20
NO781970L (no) 1978-12-08
FR2393804B1 (xx) 1980-11-07
SE436206B (sv) 1984-11-19
YU117078A (en) 1983-01-21
FR2393805B1 (xx) 1984-02-24
NO152448B (no) 1985-06-24
EG13869A (en) 1983-03-31
IE781140L (en) 1978-12-07
NL7806126A (nl) 1978-12-11
KE3355A (en) 1983-12-16
NO152448C (no) 1985-10-02
DD148585A5 (de) 1981-06-03
SE8305916D0 (sv) 1983-10-27
FI66003C (fi) 1984-08-10
AT364084B (de) 1981-09-25
HK13184A (en) 1984-02-24
FI66003B (fi) 1984-04-30
IE47079B1 (en) 1983-12-14
MY8500092A (en) 1985-12-31
AR224111A1 (es) 1981-10-30
OA05964A (fr) 1981-06-30
HU180042B (en) 1983-01-28
GR72255B (xx) 1983-10-06
IT7824270A0 (it) 1978-06-06
AU3683878A (en) 1979-12-06
DE2824535B2 (de) 1980-05-14

Similar Documents

Publication Publication Date Title
SE447995B (sv) Mellanprodukt for framstellning av pencillansyra-1,1-dioxider
DK562078A (da) Fremgangsmaade til fremstilling af 4-hydroxy-2h-1,2-benzothiazin-3-carboxamid-1,1-dioxider
SE7803912L (sv) Forfarande for framstellning av jodoforforeningar
IT7826631A0 (it) Preparazione di oligoimmidi.
NO782484L (no) Fremgangsmaate for fremstilling av sulfobetainer
NO162561C (no) Fremgangsmaate for fremstilling av oksazolinforbindelser egnet for fremstilling av antibakterielt virksomme 1-oksa-detiacefalosporiner.
NO781168L (no) Fremgangsmaate ved fremstilling av diasepinderivater
SE7803035L (sv) Forfarande for framstellning av tienopyridinderivat
RO76721A (ro) Procedeu pentru prepararea 3.12.-hidroxi-4-fenil-cicloalcanonei
NO784382L (no) Fremgangsmaate for fremstilling av tiazoldin-derivater
FI780021A (fi) Anordning foer anvaendning av hisschaktdoerrar
NO152645C (no) Fremgangsmaate for fremstilling av klordioksyd.
NO150087C (no) Fremgangsmaate for fremstilling av cellulosemasse
SE7803900L (sv) Sett for framstellning av 2,3-dimetylpentanal
IT7828100A0 (it) Preparazione di alfa-cianobenzilesteri.
SE7802530L (sv) Forfarande for framstellning av cefalosporinforeningar
SE434266B (sv) Forfarande for framstellning av prostacyklinderivat
NO780389L (no) Fremgangsmaate for fremstilling av erytromycin-derivater
DK44278A (da) Fremgangsmaade til fremstilling af thiophenderivater
SE7809202L (sv) Forfarande for framstellning av 2-klorsulfinylazetidin-4-oner
NO155010C (no) Forbedret fremgangsmaate for fremstilling av 3-brommetyl-3-cefem-sulfoksydderivater.
NO144067C (no) Fremgangsmaate for fremstilling av di-n-propylacetonitril.
SE7805324L (sv) Forfarande for framstellning av 3-bromftalid
NO771577L (no) Fremgangsmaate for fremstilling av di-n-propylacetamid
SE7802694L (sv) Forfarande for framstellning av isobutyramidderivat

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8305916-2

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8305916-2

Format of ref document f/p: F